Manuscript Writing Service
International Journal of Clinical Obstetrics and Gynaecology

International Journal of Clinical Obstetrics and Gynaecology

Login     Signup
Print ISSN: 2522-6614, Online ISSN: 2522-6622

International Journal of Clinical Obstetrics and Gynaecology

2020, Vol. 4, Issue 1, Part B

Role of antiphospholipid antibodies in recurrent pregnancy loss
Author(s): Anu Nagpal, Prateek Girotra and Varun Gautam
Abstract: Antiphospholipid syndrome is associated with a hallmark of Obstetric complications including recurrent miscarriage, early delivery, oligohydramnios, prematurity, intrauterine growth restriction, fetal distress, fetal or neonatal thrombosis, pre-eclampsia/eclampsia, HELLP syndrome, arterial or venous thrombosis and placental insufficiency. Antiphospholipid antibodies promote activation of endothelial cells, monocytes and platelets, causing an overproduction of tissue factor and thromboxane A2. These factors lead to a hypercoagable state leading to various obstetric complications. The aim of this study was to evaluate the prevalence of anti-phospholipid antibodies in patients with RPL and to evaluate the relation of antibody positivity with other parameters.
Pages: 119-122 | 259 Views | 139 Downloads
Download Full Article: Click Here
How to cite this article:
Anu Nagpal, Prateek Girotra, Varun Gautam. Role of antiphospholipid antibodies in recurrent pregnancy loss. Int J Clin Obstet Gynaecol 2020;4(1):119-122. DOI: 10.33545/gynae.2020.v4.i1b.1124
International Journal of Clinical Obstetrics and Gynaecology